Welcome to ResMed.com
This area of our site caters to our commercial partners.
Patient Engagement Can Improve Home Medical Equipment Providers Efficiency
SAN DIEGO, May 18, 2014 —Umbian Inc., a ResMed (NYSE: RMD) company, and leading provider of cloud-based healthcare compliance solutions, today announced the outcome of a new study that shows significant, measurable efficiency gains when using the automated messaging capabilities of its U-Sleep compliance management solution.
The study reveals a 59 percent reduction in labor associated with intervening with and coaching patients on continuous positive airway pressure (CPAP) therapy when using U-Sleep. The study was presented today at the American Thoracic Society (ATS) 2014 International Conference in San Diego by lead investigator Dominic Munafo, M.D., DABSM, Medical Director, Sleep Data, Inc., and was supported by Umbian and ResMed.
“This is an opportunity for home medical equipment (HME) providers to redesign the way they interact with patients to improve efficiency, and therefore their bottom line,” said Raj Sodhi, president of Umbian. “Every HME is under pressure to minimize the costs associated with gaining compliance, and these findings show that U-Sleep’s automated messaging can help significantly.”
The goal of the study was to compare the effectiveness and coaching labor requirements of a web-based, automated messaging (via U-Sleep) with standard-of-care CPAP adherence coaching, and measure the coaching labor necessary to achieve Medicare-defined adherence. A secure and flexible compliance solution, U-Sleep monitors CPAP device usage and helps HMEs coach and manage their patients during therapy.
In order to evaluate the effect of automated messaging on coaching labor and patient adherence, researchers conducted a multi-center, prospective trial of patients newly diagnosed with obstructive sleep apnoea. A total of 122 patients completed the three-month study follow-up, with 58 in the U-Sleep arm and 64 in the standard-of-care arm. All patients were set up on a CPAP device with heated humidification and a ResMed wireless modem, and both groups received identical CPAP education and orientation.
The U-Sleep arm received an automated series of text messages and/or emails triggered by one of five situations that indicated non-compliance, such as No CPAP data for two consecutive days or CPAP usage of less than four hours for three consecutive nights. In contrast, the standard-of-care arm received scheduled telephone calls on days one, seven, 14, and 30.
Reducing Labor while Increasing Compliance
The results of the study reveal a significant reduction in the mean number of minutes of adherence coaching required per patient for the U-Sleep arm, equating to a 59 percent reduction in labor. In addition, there was an observed difference of +10 percent in Medicare-defined adherence for the U-Sleep group (83 vs. 73 percent). Medicare-defined adherence is the documented use of CPAP therapy for at least four hours per night for 70 percent or more nights during a consecutive 30-day period within the first 90 days of therapy.
As the number of people using CPAP therapy to treat sleep apnoea increases, the ability to efficiently and effectively monitor and manage CPAP therapy becomes a critical aspect of healthcare.
“Scaling to meet the growing sleep apnoea patient base requires new ways of thinking for HMEs,” said Sodhi. “Using automated messaging technology to keep patients on track with therapy has the potential to increase an HME’s patient base capacity, and improve a growing number of lives.”
For more information, the study abstract may be found here.
About Umbian Inc.
Umbian Inc. is an innovative technology company specializing in the design, development and delivery of web-based health care compliance monitoring solutions. Umbian is located in Halifax, Nova Scotia, and is a wholly-owned subsidiary of ResMed Inc., a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing.